Skip to content

P200TE and Predicate Agreement and Precision Study

P200TE Agreement and Precision Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05624593
Enrollment
125
Registered
2022-11-22
Start date
2022-11-04
Completion date
2023-03-31
Last updated
2022-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma, Normal, Retina Disease

Brief summary

This study is a prospective comparative, randomized, single center study to assess agreement and precision of the P200TE in comparison to the predicate device in normal subjects, subjects with glaucoma, and subjects with retinal disease.

Interventions

DEVICEP200TE

The P200TE Ophthalmoscope provides widefield Scanning Laser Ophthalmoscope (SLO) fundus imaging and Optical Coherence Tomography (OCT) imaging in one device.

DEVICEPredicate

The predicate device is an optical coherence tomography system intended for in vivo imaging, axial cross-sectional, three-dimensional imaging and measurement of anterior and posterior ocular structures.

Sponsors

Optos, PLC
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
22 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

for Normal Group 1. Subjects 22 years of age or older on the date of informed consent 2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. Subjects with normal eye examinations in both eyes on the date of the study visit as observed with a 90 diopter lens 4. BCVA 20/40 or better (each eye) on the date of the study visit

Exclusion criteria

for Normal Group 1. Subjects unable to tolerate ophthalmic imaging 2. Subjects not able to obtain acceptable OCT images due to ocular media opacity or other reasons 3. Subject has a condition or is in a situation which the investigator feels may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study 4. Presence of any ocular pathology except for cataract in either eye Inclusion Criteria for Glaucoma Group 1. Subjects 22 years of age or older on the date of informed consent 2. Subjects able to understand the written informed consent and willing to participate as evidenced by signing the informed consent 3. BCVA 20/40 or better in the study eye 4. History of Visual field defects within the previous year from the study visit or measured the day of the study visit consistent with glaucomatous optic nerve damage with at least one of the following two findings: 1. On pattern deviation (PD), there exists a cluster of 3 or more points in an expected location of the visual field depressed below the 5% level, at least 1 of which is depressed below the 1% level; 2. Glaucoma hemi-field test outside normal limits. 5. Glaucomatous optic nerve damage as evidenced by any of the following optic disc or retinal nerve fiber layer structural abnormalities: 1. Diffuse thinning, focal narrowing, or notching of the neuroretinal rim, especially at the inferior or superior poles with or without disc hemorrhage; 2. Optic disc neural rim asymmetry of the two eyes consistent with loss of neural tissue

Design outcomes

Primary

MeasureTime frame
Precision between the P200TE and predicate device measurements of ganglion cell complex thickness1 year
Limit of Agreement (LOA) between the P200TE and predicate device measurements of full retinal thickness.1 year
Limit of Agreement (LOA) between the P200TE and predicate device measurements of retinal nerve fiber layer thickness (μm).1 year
Limit of Agreement (LOA) between the P200TE and predicate device measurements of ganglion cell complex thickness (μm).1 year
Limit of Agreement (LOA) between the P200TE and predicate device measurements of optic disc (disc area, rim area, cup-to-disc area, cup-to-disc vertical, cup-to-disc horizontal)1 year
Precision between the P200TE and predicate device measurements of full retinal thickness1 year
Precision between the P200TE and predicate device measurements of retinal nerve fiber layer thickness.1 year
Precision between the P200TE and predicate device measurements of optic disc (disc area, rim area, cup-to-disc area, cup-to-disc vertical, cup-to-disc horizontal)1 year

Countries

United States

Contacts

Primary ContactEylse Nylin
enylin@ico.edu312-949-7000
Backup ContactJessica Martinez
jemartinez@ico.edu312-949-7000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026